Abstract Cannabis use is linked to elevated psychosis risk, yet the neurobiological mechanisms that couple use to symptom expression remain unclear. Because glutamatergic dysregulation has been implicated in both cannabis effects and psychosis vulnerability, we examined whether brain glutamate relates to dimensional symptoms as a function of cannabis use across the psychosis spectrum....
Cannabis use in youth is rising and has been linked to deficits in cognitive functioning. However, cognitive findings have primarily been based on small samples of users seeking treatment, and few studies have evaluated cognition in occasional cannabis users. Here, we examined 4,568 adolescents and young adults (ages 14–21 years) drawn from the Philadelphia Neurodevelopmental Cohort, a...
Purpose To examine how cannabis use and polysubstance use among cannabis users relate to psychosis spectrum (PS) symptoms in a large community-based sample of US youth. Methods 4,171 youth (age 14–21; mean=16.90, SD=1.85; 55% female) from the Philadelphia Neurodevelopmental Cohort (PNC) completed assessments of substance use, PS symptoms, and confounding variables (e.g., demographics, comorbid...